BERONJA, Branko et al. Tocilizumab treatment of COVID-19: relevance of delay in therapy initiation in middle-income countries. The Journal of Infection in Developing Countries, [S. l.], v. 19, n. 02, p. 192–201, 2025. DOI: 10.3855/jidc.19914. Disponível em: https://www.jidc.org/index.php/journal/article/view/40063745. Acesso em: 28 mar. 2026.